Cytochroma to present at upcoming investor conferences
MARKHAM, ON, Sept. 7, 2011 /PRNewswire/ - Cytochroma today announced that the Company will be presenting a corporate overview at the following investor conferences:
- Charles W. Bishop , Cytochroma's President and Chief Executive Officer will be presenting at the Stifel Nicolaus Healthcare Conference 2011 at 4:25 PM ET on Wednesday, September 7, 2011 at the Four Seasons Hotel in Boston.
- Eric J. Messner , Cytochroma's Chief Operating Officer will be presenting at the RW Baird 2011 Health Care Conference at 1:45 PM ET on Thursday, September 8, 2011 at The New York Palace Hotel in New York City.
About Cytochroma
Cytochroma is a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary products to treat and prevent the clinical consequences of vitamin D insufficiency and secondary hyperparathyroidism associated with chronic kidney disease (CKD). The Company specializes in developing new therapies which are designed to safely and effectively treat patients with stage 3, 4 or 5 CKD. Cytochroma also has a portfolio of CYP24 and phosphate-uptake inhibitors in early stage development.
For more information about Cytochroma, please visit www.cytochroma.com.
SOURCE Cytochroma
More by this Source
OPKO Health s'apprête à acquérir la société privée Cytochroma
Jan 09, 2013, 10:46 ET
OPKO Health kauft das Privatunternehmen Cytochroma auf
Jan 09, 2013, 09:01 ET
OPKO Health to acquire privately held Cytochroma
Jan 08, 2013, 18:01 ET
Featured Video
Journalists and Bloggers
Visit PR Newswire for Journalists for releases, photos, ProfNet experts, and customized feeds just for Media.
View and download archived video content distributed by MultiVu on The Digital Center.
Custom Packages
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.